Cargando…
B7-H3 specific CAR-T cells exhibit potent activity against prostate cancer
B7-H3 is an attractive target for immunotherapy because of its high expression across multiple solid tumors, including prostate cancer, and restricted expression in normal tissues. Among various types of tumor immunotherapy, chimeric antigen receptor T (CAR-T) cell therapy has shown remarkable succe...
Autores principales: | Li, Shibao, Zhang, Miaomiao, Wang, Meng, Wang, Haiting, Wu, Han, Mao, Lijun, Zhang, Meng, Li, Huizhong, Zheng, Junnian, Ma, Ping, Wang, Gang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10164129/ https://www.ncbi.nlm.nih.gov/pubmed/37149721 http://dx.doi.org/10.1038/s41420-023-01453-7 |
Ejemplares similares
-
B7-H3-Targeted CAR-T Cells Exhibit Potent Antitumor Effects on Hematologic and Solid Tumors
por: Zhang, Zongliang, et al.
Publicado: (2020) -
iNKT: A new avenue for CAR-based cancer immunotherapy
por: Liu, Yilin, et al.
Publicado: (2022) -
Tandem CAR-T cells targeting CD70 and B7-H3 exhibit potent preclinical activity against multiple solid tumors
por: Yang, Meijia, et al.
Publicado: (2020) -
Recombinant oncolytic adenovirus armed with CCL5, IL-12, and IFN-γ promotes CAR-T infiltration and proliferation in vivo to eradicate local and distal tumors
por: Fang, Lin, et al.
Publicado: (2023) -
GPC3-targeted CAR-T cells secreting B7H3-targeted BiTE exhibit potent cytotoxicity activity against hepatocellular carcinoma cell in the in vitro assay
por: Cao, Guozheng, et al.
Publicado: (2022)